Published in Int J Health Geogr on December 18, 2006
Enhanced expression of SOS1 is detected in prostate cancer epithelial cells from African-American men. Int J Oncol (2009) 1.13
A prospective study of socioeconomic status, prostate cancer screening and incidence among men at high risk for prostate cancer. Cancer Causes Control (2012) 0.88
Evaluation of the performance of tests for spatial randomness on prostate cancer data. Int J Health Geogr (2009) 0.78
Fate of the human Y chromosome linked genes and loci in prostate cancer cell lines DU145 and LNCaP. BMC Genomics (2013) 0.77
Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. IARC Sci Publ (1987) 27.11
Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States. Cancer Epidemiol Biomarkers Prev (2005) 2.19
Small area mapping of prostate cancer incidence in New York State (USA) using fully Bayesian hierarchical modelling. Int J Health Geogr (2004) 2.02
A geographic analysis of prostate cancer mortality in the United States, 1970-89. Int J Cancer (2002) 1.94
Geographical clustering of prostate cancer grade and stage at diagnosis, before and after adjustment for risk factors. Int J Health Geogr (2005) 1.94
Lumping or splitting: seeking the preferred areal unit for health geography studies. Int J Health Geogr (2005) 1.62
Geographic distribution of prostate cancer incidence in the era of PSA testing, Connecticut, 1984 to 1998. Urology (2004) 1.60
Epidemiology of prostate cancer. CA Cancer J Clin (1997) 1.56
What can geography tell us about prostate cancer? Am J Prev Med (2006) 1.51
Spatial analysis of prostate cancer incidence and race in Virginia, 1990-1999. Am J Prev Med (2006) 1.33
Generalized additive models for cancer mapping with incomplete covariates. Biostatistics (2004) 1.29
A population-based survey of prostate-specific antigen testing among California men at higher risk for prostate carcinoma. Cancer (2006) 1.28
Methods to evaluate geographic access to health services. J Public Health Manag Pract (1999) 1.27
Clusters of census tracts with high proportions of men with distant-stage prostate cancer incidence in New Jersey, 1995 to 1999. Am J Prev Med (2006) 1.17
Hierarchical modeling and other spatial analyses in prostate cancer incidence data. Am J Prev Med (2006) 1.12
The epidemiology of prostate cancer part I: descriptive epidemiology. Semin Urol Oncol (1998) 1.05
Prostate cancer in the African American: is this a different disease? Semin Urol Oncol (1998) 1.03
The epidemiology of prostate cancer part II: the risk factors. Semin Urol Oncol (1998) 0.98
Recent changes in the spatial pattern of prostate cancer in the U.S. Am J Prev Med (2006) 0.87
Cancer map patterns: are they random or not? Am J Prev Med (2006) 1.79
Lumping or splitting: seeking the preferred areal unit for health geography studies. Int J Health Geogr (2005) 1.62
Geographic distribution of prostate cancer incidence in the era of PSA testing, Connecticut, 1984 to 1998. Urology (2004) 1.60
The geographic distribution of breast cancer incidence in Massachusetts 1988 to 1997, adjusted for covariates. Int J Health Geogr (2004) 1.59
Geographic differences in invasive and in situ breast cancer incidence according to precise geographic coordinates, Connecticut, 1991-95. Int J Cancer (2002) 1.45
Effects of study area size on geographic characterizations of health events: prostate cancer incidence in Southern New England, USA, 1994-1998. Int J Health Geogr (2006) 1.21
Brain cancer mortality in the United States, 1986 to 1995: a geographic analysis. Neuro Oncol (2004) 1.11
Is surgery a risk factor for Creutzfeldt-Jakob disease? Outcome variation by control choice and exposure assessments. Infect Control Hosp Epidemiol (2008) 0.86
Marital status and variability in cortisol excretion in postmenopausal women. Biol Psychol (2007) 0.85
Breast cancer surveillance using gridded population units, Connecticut, 1992 to 1995. Ann Epidemiol (2003) 0.84
Place of residence effect on likelihood of surviving prostate cancer. Ann Epidemiol (2007) 0.82
Prevalence and prognostic role of triple-negative breast cancer by race: a surveillance study. Clin Breast Cancer (2011) 0.81
Polity and health care expenditures: the association among 159 nations. J Epidemiol Glob Health (2013) 0.81
Who's assessing tobacco use in cancer clinical trials? Nicotine Tob Res (2009) 0.81
Prostate cancer incidence in light of the spatial distribution of another screening-detectable cancer. Spat Spatiotemporal Epidemiol (2013) 0.78
The National Board of Public Health Examiners: credentialing public health graduates. Public Health Rep (2007) 0.78
Secular trends, race, and geographic disparity of early-stage breast cancer incidence: 25 years of surveillance in Connecticut. Am J Public Health (2015) 0.77
Patterns of HER2 testing in the management of primary breast cancer. Cancer Epidemiol (2009) 0.77